ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 375162 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 375162; 2) Community: the network communities that were significantly associated with the response to NSC 375162; 3) Molecule: the relationships between components within communities and NSC 375162; 4) MDR: the compounds that were significantly associated with the NSC 375162.

NSC Compound Enrichment Correlation
NSC 676914 2-(4-((4-amino-2-methylphenyl)diazenyl)phenylsulfonyl)ethanesulfonoperoxoic acid 0.0295480456086947 0.21754402
NSC 677776 Null 0.0295480456086947 -0.18295474
NSC 678925 1-Phenazinecarboxamide, N-[2-(dimethylamino)ethyl]- 9-fluoro-, monohydrochloride 0.0295480456086947 0.30466094
NSC 681636 Camptothecin Derivative 0.0295480456086947 0.27280154
NSC 681645 Camptothecin Derivative 0.0295480456086947 0.33074953
NSC 682011 Benzimidazo[1,2-b]isoquinoline-6-carbonitrile, 7,8,9,10-tetrahydro-11-[(4-fluorophenyl)amino]- 0.0295480456086947 0.084025443
NSC 687305 4-(N-acetyl-N-ethylamino)isoquinoline-1-carboxaldehyde thiosemicarbazone 0.0295480456086947 0.40422454
NSC 688021 Phosphorodiamidic acid, N,N-bis(2-bromoethyl)-, (5-nitro-2-thienyl)methyl ester 0.0295480456086947 0.40971829
NSC 692638 Null 0.0295480456086947 0.076267445
NSC 696257 2,3-Dihydro-1,2-syn-2-[S-(L)-cysteinylsulfoxide-]-brefeldin A 0.0295480456086947 -0.02990016
Total:112  Current:85    [First] [Prev] [Next] [Last]